about
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.Association of hyperglycemia and insulin with diabetic cardiovascular complications.A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.Diet and coronary heart disease in diabetes.Metabolic syndrome--practical approach.Heart failure and diabetes.Effect of the early intensive multifactorial therapy on the cardiovascular risk in patients with newly diagnosed type 2 diabetes: an observational, prospective study.Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.276G>T Polymorphism of the ADIPOQ Gene Influences Plasma Adiponectin in Type 2 Diabetes Patients but Is Not Predictive for Presence of Type 2 Diabetes in a Caucasian Cohort from RomaniaReverse cholesterol transport and atherosclerosis. A mini review.Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS)Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.Associations of smoking with cardiometabolic profile and renal function in a Romanian population-based sample from the PREDATORR cross-sectional study.Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.Prevalence of chronic kidney disease and its association with cardio-metabolic risk factors in the adult Romanian population: the PREDATORR study.Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease.Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study.Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study.Effect of two starting insulin regimens in patients with type II diabetes not controlled on a combination of oral antihyperglycemic medications.Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation.Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up.Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.Hypertensive waist: first step of the screening for metabolic syndrome.Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis.Relationship of endothelial cell selective adhesion molecule to markers of oxidative stress in type 2 diabetes.40th EASD Annual Meeting of the European Association for the Study of DiabetesLow plasma adiponectin levels predict increased urinary albumin/creatinine ratio in type 2 diabetes patients35th Annual Meeting of the European Association for the Study of DiabetesSerum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetesIncreased Soluble Interleukin-2 Receptor Concentrations in Patients with Insulin-dependent Diabetes Mellitus[Correlation of plasma lipids and microproteinuria in diabetes mellitus][Serum triglyceride changes in diabetes mellitus (pathogenetic and diagnostic significance)][Control of diabetes mellitus during surgery]Serum lipoprotein(a) is increased in hypertensive NIDDM patientsHigh glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cellsInterleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals
P50
Q33646780-FE9935A9-64E8-474C-80C1-6AFCC4019B44Q35098384-0A78E2B4-EF43-4F5D-A881-5A9741878078Q35529668-31744435-AF94-4C34-98B1-B907C06F4E0EQ35620164-40A7B629-1FF3-49F5-8B2A-467788704BA1Q35941229-F90136E6-364D-4916-BC51-CCC6059F1963Q35941245-A5FE2915-4864-408B-83AE-E4630A44B557Q36078054-D1FCA44C-C0E4-48B3-A352-DB203E15904DQ36649345-7EEE30CD-31FF-4E13-AF28-F239EEA0BEFEQ36671257-04033B61-612D-4BD5-8362-44A2644B88C1Q36984077-65FB1756-EE5B-4418-AC23-C6636841018FQ37067081-E92C942D-7099-4E23-B27E-913E99210140Q37392188-595E66B2-5570-45E9-B617-78EEF54DAABCQ37681585-2D5A1975-628F-4AA8-8ECA-E4E8795D6F33Q38575410-37A90299-E979-45EF-8696-45E9EFB2B429Q38735893-097CA577-239F-4A77-B853-D165476A9203Q39180567-BDDCF135-B67A-4FCB-809D-E3089A2C01B8Q40532134-A3CAA5CE-5502-4C34-94CB-64EA128E0530Q40569748-2F852B5A-E570-4302-9C70-9F4E98777F6CQ40776991-17E46374-EDFC-43A2-B31B-A7094FA29DE5Q41104758-FEC16810-BD03-417F-A85B-2462EF196AC5Q43776383-1406CFA4-FE67-4D36-B1A4-544EAC5AF4E5Q44662236-E61E214A-2EBB-4C0A-AE04-7DEE52A6C6CFQ45144137-12C0E8F3-9042-481D-9089-EF50FC0D0EC2Q46134298-B5490A0E-2960-428A-AE30-97FB41CC0C1AQ46195706-8A166541-2624-4DD2-AEFE-770901C6E40FQ46229855-ABEEBA15-119B-484E-9AD6-363B19E78409Q47868741-73804E31-F837-49CD-8EDD-74C695325975Q51245078-00784F91-93AD-4F65-A010-A0A0058E86AFQ53070935-8F21678E-98FE-4339-8819-7D3A2BC078D8Q57249806-30457829-982C-4568-BAB2-7E9B6420A86EQ57580560-FBC9A1CA-5176-4EC2-90E5-52471F004A66Q57920219-1047CC64-9118-4251-A594-F50D42A2B3F4Q60681654-1819BFBD-C443-41B4-81D1-AFE462C312CEQ67227819-68006E17-D047-4105-8F89-2A48B1FC7AE7Q67807474-004DE132-3EEB-498D-A9F0-5F3E285D3C41Q68692163-6C41D72E-8E52-48C7-BB3B-CFBB4B9BCF91Q70035140-4F0566F1-3EE1-4BCE-A86D-FEE24ED78497Q71733485-2C8F37C1-1FB7-492B-8F98-224D37F516F5Q73147989-26B4FF9D-7CE2-428D-8A1F-774054BDF033Q73251420-760F4945-BF6B-4387-915C-222EA053F041
P50
description
researcher, ORCID id # 0000-0002-4688-5110
@en
wetenschapper
@nl
name
N. Hancu
@ast
N. Hancu
@nl
Nicolae Hancu
@en
type
label
N. Hancu
@ast
N. Hancu
@nl
Nicolae Hancu
@en
altLabel
N. Hancu
@en
prefLabel
N. Hancu
@ast
N. Hancu
@nl
Nicolae Hancu
@en
P106
P21
P31
P496
0000-0002-4688-5110